{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:15:55Z","timestamp":1788477355109,"version":"build-2803163510"},"reference-count":37,"publisher":"Georg Thieme Verlag KG","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Laryngorhinootologie"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1055\/a-2606-7872","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:30:33Z","timestamp":1788474633000},"page":"587-599","source":"Crossref","is-referenced-by-count":0,"title":["HPV-assoziierte Oropharynxkarzinome in der 9. Ausgabe der TNM-Klassifikation"],"prefix":"10.1055","volume":"105","author":[{"given":"Silke","family":"Tribius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1358-7029","authenticated-orcid":false,"given":"Markus","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","volume-title":"AJCC Cancer Staging Manual","author":"MB Amin","year":"2017"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study","volume":"17","author":"B O\u02bcSullivan","year":"2016","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0043-123028","article-title":"HPV bei Oropharynxkarzinomen in der 8. Ausgabe der TNM-Klassifikation","volume":"97","author":"M Hoffmann","year":"2018","journal-title":"Laryngo-Rhino-Otol"},{"key":"ref4","volume-title":"TNM Classification of Malignant Tumours","author":"Union for International Cancer Control (UICC)","year":"2024"},{"issue":"04","key":"ref5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4274\/tao.2025.2025-11-14","article-title":"Society for Head and Neck Surgery Scientific Group. Union for International Cancer Control 9th Edition TNM Classification for Head and Neck Malignancies: What is New?","volume":"63","author":"A Bayram","year":"2025","journal-title":"Turk Arch Otorhinolaryngol"},{"issue":"01","key":"ref6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"KK Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1055\/a-1509-8851","article-title":"Eine \u00c4nderung des Rauchverhaltens beeinflusst das \u00dcberleben von HNSCC-Patienten","volume":"100","author":"A Fazel","year":"2021","journal-title":"Laryngo-Rhino-Otol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1055\/a-1509-8883","article-title":"Rauchen und Komorbidit\u00e4t ohne Einfluss auf geplante Zieldosis der Radio(chemo)therapie","volume":"100","author":"A Fazel","year":"2021","journal-title":"Laryngo-Rhino-Otol"},{"issue":"04","key":"ref9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/lary.28059","article-title":"Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma","volume":"130","author":"E Bauer","year":"2020","journal-title":"Laryngoscope"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.radonc.2019.10.011","article-title":"Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining the TNM-8 cN-classification","volume":"144","author":"SH Huang","year":"2020","journal-title":"Radiother Oncol"},{"issue":"13","key":"ref11","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.3390\/cancers15133276","article-title":"Assessment of radiologic extranodal extension using combinatorial analysis of nodal margin breakdown and metastatic burden in oropharyngeal cancer","volume":"15","author":"S Kim","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"02","key":"ref12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s11547-024-01929-1","article-title":"Nodal assessment and extranodal extension in head and neck squamous cell cancer: insights from computed tomography and magnetic resonance imaging","volume":"130","author":"N Maggialetti","year":"2025","journal-title":"Radiol Med"},{"issue":"12","key":"ref13","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1002\/hed.27183","article-title":"Correlation between radiologic and pathologic extranodal extension in HPV-associated oropharyngeal cancer: systematic review","volume":"44","author":"JR Morey","year":"2022","journal-title":"Head Neck"},{"issue":"02","key":"ref14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1","volume":"45","author":"EA Eisenhauer","year":"2009","journal-title":"1). Eur J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41416-025-03291-z","article-title":"Correlation between imaging-detected and pathological extranodal extension in a randomised trial in Human papillomavirus-positive oropharyngeal cancer","volume":"134","author":"M Evans","year":"2026","journal-title":"Br J Cancer"},{"issue":"03","key":"ref16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1470-2045(23)00013-X","article-title":"Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicenter, multinational, individual patient data analysis","volume":"24","author":"H Mehanna","year":"2023","journal-title":"Lancet Oncol"},{"issue":"06","key":"ref17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3390\/v13061173","article-title":"Relevance of human papillomaviruses in head and neck cancer \u2013 what remains in 2021","volume":"13","author":"M Hoffmann","year":"2021","journal-title":"Viruses"},{"issue":"01","key":"ref18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3892\/ijo.2014.2697","article-title":"Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany","volume":"46","author":"ES Quabius","year":"2015","journal-title":"Int J Oncol"},{"issue":"11","key":"ref19","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/ijc.22980","article-title":"A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimens","volume":"121","author":"SJ Smeets","year":"2007","journal-title":"Int J Cancer"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.anorl.2015.01.003","article-title":"Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma","volume":"132","author":"D Fonmarty","year":"2015","journal-title":"Eur Ann Otorhinolaryngol Head Neck"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S1470-2045(14)70471-1","article-title":"HPV DNA, E6\/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis","volume":"15","author":"C Ndiaye","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.oraloncology.2012.05.022","article-title":"HPV status in patients with head and neck carcinoma of unknown primary site: HPV, tobacco smoking, and outcome","volume":"48","author":"S Tribius","year":"2012","journal-title":"Oral Oncol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/lary.27475","article-title":"HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes","volume":"129","author":"S Cheraghlou","year":"2019","journal-title":"Laryngoscope"},{"issue":"07","key":"ref24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.20892\/j.issn.2095-3941.2025.0170","article-title":"Dissection of the TNM staging classification for nasopharyngeal cancer \u2013 past, present, and future","volume":"22","author":"Q Liu","year":"2025","journal-title":"Cancer Biol Med"},{"issue":"04","key":"ref25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/cncr.29795","article-title":"Proposal for the 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy","volume":"122","author":"JJ Pan","year":"2016","journal-title":"Cancer"},{"issue":"20","key":"ref26","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1093\/jnci\/94.21.1614","article-title":"Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma","volume":"94","author":"ATC Chan","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"01","key":"ref27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/v15010066","article-title":"The dynamic change in plasma Epstein-Barr virus DNA load over a long-term follow-up period predicts prognosis in nasopharyngeal carcinoma","volume":"15","author":"A Gihbid","year":"2022","journal-title":"Viruses"},{"issue":"02","key":"ref28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/bjc.2013.639","article-title":"Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer","volume":"110","author":"MJ Ward","year":"2014","journal-title":"Br J Cancer"},{"issue":"06","key":"ref29","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/bjc.2015.277","article-title":"Stromal infiltration of CD8+ T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma","volume":"113","author":"KK Oguejiofor","year":"2015","journal-title":"Br J Cancer"},{"issue":"07","key":"ref30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s40425-019-0726-6","article-title":"Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells","volume":"7","author":"K Hlad\u00edkov\u00e1","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"17","key":"ref31","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1038\/s41388-023-02819-y","article-title":"Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer","volume":"42","author":"YX Lim","year":"2023","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12885-015-1598-x","article-title":"Pathos: a phase II\/III trial of risk-stratified, reduced-intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV) positive oropharyngeal cancer","volume":"15","author":"W Owadally","year":"2015","journal-title":"BMC"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN cancer research group trial (E3311)","volume":"40","author":"RL Ferris","year":"2022","journal-title":"J Clin Oncol"},{"issue":"22","key":"ref34","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1200\/JCO.20.00056","article-title":"De-escalation after DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup framework for future de-escalation studies","volume":"38","author":"H Mehanna","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"ML Gillison","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"ref36","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/healthcare12101014","article-title":"Role of TORS as de-escalation strategy in HPV-related oropharyngeal cancer: what we need to know","volume":"12","author":"G Molteni","year":"2024","journal-title":"Healthcare (Basel)"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"107685","DOI":"10.1016\/j.oraloncology.2025.107685","article-title":"Transcriptomic based prognostic model versus TNM 9th edition in HPV-positive oropharyngeal cancer","volume":"170","author":"S Cavalieri","year":"2025","journal-title":"Oral Oncol"}],"container-title":["Laryngo-Rhino-Otologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2606-7872.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:30:46Z","timestamp":1788474646000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2606-7872"}},"subtitle":["Klinische Einordnung und Konsequenzen"],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2026,9,3]]},"published-print":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2606-7872","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0935-8943","1438-8685"],"issn-type":[{"value":"0935-8943","type":"print"},{"value":"1438-8685","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}